Revivegen Co., Ltd. (7578.TWO)

TWD 35.2

(0.28%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 393.58 Million 339.16 Million 337 Million 196.4 Million 168.97 Million
Cost of Revenue 282.93 Million 223.13 Million 241.52 Million 133.83 Million 100.75 Million
Gross Profit 110.64 Million 116.02 Million 95.48 Million 62.57 Million 68.22 Million
Operating Expenses 80.61 Million 72.85 Million 48.84 Million 45.8 Million -
Selling, General and Administrative Expenses 75.33 Million 65.75 Million 45.96 Million 44.35 Million -
Research and Development Expenses 4.78 Million 4.32 Million 2.87 Million 1.45 Million -
Other Expenses 497 Thousand -447 Thousand 2.37 Million 1.64 Million -
Cost and Expenses 363.55 Million 295.99 Million 290.36 Million 179.64 Million 100.75 Million
Operating Income 30.03 Million 43.94 Million 49.06 Million 18.28 Million 68.22 Million
Interest Expense 9.21 Million 5.7 Million 3.65 Million 3.96 Million -
Income Tax Expense 11.31 Million 12.47 Million 9.99 Million 3.04 Million 6.05 Million
Earnings before Tax 47.3 Million 38.24 Million 45.41 Million 14.31 Million 26.14 Million
Net Income 40.81 Million 35.14 Million 35.57 Million 11.27 Million 20.08 Million
Earnings Per Share Basic 0.82 1.19 1.39 0.48 0.75
Earnings Per Share Diluted 0.82 0.96 1.35 0.47 0.75
Weighted Average Shares Outstanding 49.49 Million 36.42 Million 26.33 Million 23.8 Million 26.93 Million
Weighted Average Shares Outstanding (Diluted) 49.71 Million 36.58 Million 26.37 Million 23.71 Million 26.93 Million
Gross Margin 0.28 0.34 0.28 0.32 0.40
EBIT Margin 0.36 0.36 0.32 0.27 0.38
Profit Margin 0.10 0.10 0.11 0.06 0.12
EBITDA 142.06 Million 122.82 Million 106.69 Million 53.77 Million 64.96 Million
Earnings Before Tax Margin 0.08 0.13 0.15 0.09 0.40

Income Statement Charts